{"schema_version":"1","generated_at":"2026-11-07T05:32:23.752Z","data_as_of":null,"url":"https://www.findmykol.com/kol/roman-shapiro","json_url":"https://www.findmykol.com/kol/roman-shapiro/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"roman-shapiro","name":"Roman Shapiro","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1932765682","orcid":"0000-0002-7622-8322","openalex":"A5014845006"},"summary":"Roman Shapiro is a Hematology physician affiliated with Harvard University. OpenAlex indexes 123 publications with 1,115 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":123,"cited_by_count":1115,"h_index":17,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06138587","title":"Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06138587","trial_url":"https://www.findmykol.com/trial/NCT06138587"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Pfizer","program_year":2025,"amount_usd":20000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932765682"},{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":8022,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932765682"},{"payer":"Pfizer","program_year":2022,"amount_usd":4000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932765682"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1932765682","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":36.5,"classes_total":2,"classes":[{"class":"Bile Acid","setting":"prescribed","share_pct":23.1,"drugs":[{"name":"Ursodiol","share_pct":100}],"max_beneficiaries":22},{"class":"Corticosteroid","setting":"prescribed","share_pct":13.5,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":16,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":16,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":11}]},{"area":"Anti-infectives","share_pct":15.4,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":15.4,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":14}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco-25-03104","status":"verified"},{"title":"Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation","year":2026,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025018431","status":"verified"},{"title":"First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer","year":2025,"journal":"Journal of Hematology & Oncology","source_url":"https://doi.org/10.1186/s13045-025-01669-3","status":"verified"},{"title":"iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma","year":2025,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(24)02524-8","status":"verified"},{"title":"Poor Engraftment After Posttransplant Cyclophosphamide Graft‐Versus‐Host Disease Prophylaxis in Patients With Myelofibrosis","year":2025,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.27741","status":"verified"}],"source":"works"},"contact":{"address_1":"450 BROOKLINE AVE","address_2":"DANA 200 C5 ATTN KATIEN KUPFERBERG","city":"Boston","state":"MA","zip":"02215","phone":"617-632-6139","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1932765682","source":"identity"},"similar":[{"name":"Thoralf Sundt","slug":"thoralf-sundt","institution":"Harvard University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/thoralf-sundt","json_url":"https://www.findmykol.com/kol/thoralf-sundt/profile.json"},{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-09-15","provider_certified":"2025-09-15","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}